Regional Social Governance Innovation Research Center, Guangxi University, Nanning 530004, China.
School of Public Policy and Management, Guangxi University, Nanning 530004, China.
Int J Environ Res Public Health. 2022 Jan 25;19(3):1339. doi: 10.3390/ijerph19031339.
Vaccination plays an essential role in the fight against Coronavirus Disease 2019 (COVID-19). The currently insufficient vaccine production capacity makes it difficult to balance supply with demand, which has led to a contradiction between command demand and limited supply. According to analysis based on game theory, the attributes of COVID-19 vaccines vary with supply strategies formulated by vaccine-producing countries. This means that vaccine-receiving countries can only be motivated to prepare operable vaccine distribution plans through the supply of COVID-19 vaccines as global public goods. The rational distribution of global public goods must be guaranteed by a global supply institution system. To that end, Elinor Ostrom's eight design principles provide a basis for designing such a global supply system. This paper proposes a nested institution solution for guaranteeing the global supply of COVID-19 vaccines based on the design principles, which include clearly defined boundaries, proportional equivalence between benefits and costs, collective-choice arrangements, monitoring, graduated sanctions, conflict-resolution mechanisms, minimal recognition of rights to organize, and nested enterprises. To win this global fight against COVID-19, COVID-19 vaccines must not only be treated as global public goods, but countries must also be urged to coordinate cooperation in global institutional design, thus ensuring that COVID-19 vaccines can truly benefit all mankind.
接种疫苗在抗击 2019 年冠状病毒病(COVID-19)方面发挥着重要作用。目前疫苗生产能力不足,难以平衡供需,导致供需矛盾突出。根据博弈论分析,COVID-19 疫苗的属性因疫苗生产国制定的供应策略而异。这意味着,只有通过提供 COVID-19 疫苗作为全球公共产品,才能激励疫苗接收国制定可行的疫苗分发计划。全球公共产品的合理分配必须由全球供应机构体系来保证。为此,埃莉诺·奥斯特罗姆的八项设计原则为设计这样的全球供应体系提供了依据。本文提出了一种基于设计原则的嵌套式制度解决方案,以保障 COVID-19 疫苗的全球供应,包括明确界定边界、利益与成本的比例对等、集体选择安排、监测、分级制裁、冲突解决机制、最小化组织权利的认可以及嵌套式企业。为了赢得这场全球抗击 COVID-19 的战斗,COVID-19 疫苗不仅必须被视为全球公共产品,而且各国还必须敦促在全球制度设计方面进行协调合作,从而确保 COVID-19 疫苗真正造福全人类。